I will venture back over here to I-hub to respond:
GS, Thanks for your answer. Dr. Moro can feel free to comment in his next Answers if he disagrees.
What I was trying to get at is that, a biomarker may be listed in the patent application, the patent may get approved, the test may be a success, but the biomarkers listed in the patent application may or may not ever be included in the test. So an approved test does not guarantee future revenues unless the biomarker is included.
So what is the chance that the patent is approved, tests sold, but recaf never used in the test?
mcd
